UAB medical cannabis researcher resigns from AMCC
BIRMINGHAM, Ala. ( WBRC ) - A leading medical cannabis researcher at UAB is resigning his seat on the commission charged with making sure medical cannabis gets into the hands of patients.
Dr. Jerzy Szaflarski’s resignation from the Alabama Medical Cannabis Commission (AMCC) will take effect Monday, April 15.
Szaflarski is the Director of UAB’s Epilepsy Center and has been on the AMCC since 2021, and has spoken extensively about the benefits of medical cannabis for some patients.
AMCC Spokesperson Brittany Peters says, “He stated that he is resigning from the Commission due to multiple time constraints imposed by his current position.”
His resignation comes as the Commission is now almost a year behind schedule in issuing the first set of licenses to get products to patients - a process they’ve tried and failed to do three times since last summer and are now tied up in court in multiple lawsuits alleging the commission didn’t follow the law.
A new bill that would increase the number of licenses the commission can give out and effectively end the legal battle could get a vote in committee this week.
Get news alerts in the Apple App Store and Google Play Store or subscribe to our email newsletter here .
Copyright 2024 WBRC. All rights reserved.
Juvenile in custody after 16-year-old shot, killed in his car leaving Birmingham convenience store
First Alert Weather: More rain, even a few rumbles possible overnight and on Thursday
8-year-old died from fentanyl, not allergic reaction to strawberries, coroner says
Man found shot to death inside Pell City home; 29-year-old man charged with murder
Irondale man indicted on terrorism charge for detonating explosive at AG’s Office
Latest news.
Lifestyle Reset Health Fair happening at Legion Field
Ala. Senator Melson sponsors bill to remove some licensing power from AMCC
Inaugural AMP Ride to support individuals living with ALS, MS and Parkinson’s
Trend shows cancer developing more in younger people
IMAGES
VIDEO
COMMENTS
The clinical trials process includes three phases, which lead to approval or further research. Each phase involves more participants than the one before it. A treatment will not advance through the phases unless the results from each phase continue to show that it is safe and effective. Phase I clinical trials usually test the treatment on ...
Discovery thrives here. From basic science exploration to clinical trial excellence, the UAB Heersink School of Medicine provides an extraordinary environment for innovative biomedical research to flourish and succeed. As the home of one of the country's foremost NIH-funded Centers for Clinical and Translational Science, UAB is swiftly moving ...
Participants in the study must: be 18 to 65 years of age; live in defined zip codes, 35207, 35217, 35214; and fulfill other eligibility criteria to include a medical and medication history for evaluation. For more information, please call (205) 996-1769 or email [email protected]. Tagged under. adults.
Clinical Trials. UAB defines a clinical trial as "a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes." Examples of intervention include: drugs ...
The CCTS supports cutting-edge expertise and facilities for investigators conducting human subjects research. Our cost-effective, quality services exemplify best practice for every stage of the clinical research study lifecycle, from start up through implementation to close out. Our Clinical Translation staff also offers trainings, from a lunch ...
UAB is an active participant in research and clinical trials. Clinical trials are a way for doctors to prove or disprove the value of a new treatment or device. These medical studies also may provide access to options that are not available elsewhere.
Call 205-934-6669 or email CRU Nurse Manager Joshua Vernon to schedule appointments for participants. A series of visits may be scheduled at one time to ensure availability of resources. Outpatient: 15th floor of Jefferson Tower (625 19th Street S.). Inpatient: 8th floor Medical Education Building (1813 6th Ave. S.).
The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Tiffany at 205-934-0534 or email us at [email protected]. Tagged under.
The UAB Division of Pulmonary, Allergy, and Critical Care Medicine engages in a wide variety of clinical trials, collaborating with multiple schools and colleges, located both at UAB and around the world. You can view our current clinical trials, sorted by condition/therapy, below. Acute Respiratory Distress Syndrome. Asthma. Bronchial Thermoplasty
UAB Rheumatology Arthritis Database and Repository (RADAR) Genome research in African American scleroderma patients (GRASP Study) Clinical trials for patients with moderate to severe active systemic lupus erythematosus; Immune Tolerance Network; Clinical trials for patients with Type I Interferon-Mediated Autoimmune Diseases
A clinical trial is one of the final stages of a long and rigorous research process. The search for new treatments begins in the laboratory, where scientists first develop and test new ideas. If an approach seems promising, the next step may be testing a treatment in animals to see how it affects cancer in a living being. Clinical trials are ...
The section of Advanced Heart Failure and Pulmonary Vascular Disease is a big part of UAB's Cardiovascular Clinical Trial Unit. We are actively participating in a number of clinical trials and national registries. Our focus is on HFrEF including familal, dilated cardiomyopathy, HFpEF including amyloid cardiomyopathy, pulmonary arterial ...
According to the Blue Ridge Institute for Medical Research, the Heersink School of Medicine received nearly $274 million in research funding from the National Institutes of Health (NIH) in 2023. This is an increase of 6.2% and $17 million since 2019, and the school's highest NIH funding total ever achieved.
NCT01760005. DIAN-TU: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. UAB Investigator: Dr. Roberson. Study Coordinator: Amber Watkins (205-934-0946)
Advising opens a new website Undergraduate Catalog opens a new website Request Info opens a new website Research and Service Learning opens a new website
The budget for a clinical trial will be a per-patient or per visit budget, with additional items like start-up costs and UAB Industry-Funded Clinical Trials Fees invoiced separately. Once you have an agreement, a final protocol, and you've submitted to FAP, you should submit your clinical trial to OSP for review by emailing the required ...
Current Research Studies. The Center for Women's Reproductive Health has a number of current research studies pertaining to women's health, including some for expecting mothers, specifically.
UAB defines a clinical trial as "a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.". Examples of intervention include: drugs; small molecules; compounds; biologics; devices; procedures (i.e ...
Prevention and Treatment of Missing Data in Clinical Trials. Scott Emerson, MD, PhD, Professor of Biostatistics, University of Washington. Overview of the various estimates that might be addressed in a clinical trial so as to account for the eventuality of missing data; an approach to defining sensitivity analyses that first defines a missing ...
The section of Advanced Heart Failure and Pulmonary Vascular Disease is a big part of UAB's Cardiovascular Clinical Trial Unit. We are actively participating in a number of clinical trials and national registries. Our focus is on HFrEF including familal, dilated cardiomyopathy, HFpEF including amyloid cardiomyopathy, pulmonary arterial ...
To see UAB Medicine clinical trials, click the button below: UAB Medicine clinical trials. You can also join ResearchMatch, a multi-institution project that pairs volunteers with researchers seeking study participants. ... age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB ...
According to the Blue Ridge Institute for Medical Research, the Heersink School of Medicine received nearly $274 million in research funding from the National Institutes of Health (NIH) in 2023. This is an increase of 6.2% and $17 million since 2019, and the school's highest NIH funding total ever achieved.
ACOG Practice Bulletin. Evidence-based documents that summarize current information on techniques and clinical management issues for the practice of obstetrics and gynecology. Last Updated: Apr 8, 2024 4:55 PM. URL: https://guides.library.uab.edu/OBGYN. Print Page.
BIRMINGHAM, Ala. - A leading medical cannabis researcher at UAB is resigning his seat on the commission charged with making sure medical cannabis gets into the hands of patients.Dr. Jerzy Szaflarski's resignation from the Alabama Medical Cannabis Commission (AMCC) will take effect Monday, April 15. Szaflarski is the Director of UAB's Epilepsy Center and has been on the AMCC since 2021, and ...